IP Library Granted Patent US 6,852,491
Granted Patent B2
US 6,852,491 · App. 09/945,943 · Granted Feb 8, 2005

Amplification and detection reagents for HIV-1

Assignee: Abbott Laboratories
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,852,491
App. No.
09/945,943
Granted
Feb 8, 2005
Kind
B2
Abstract

Oligonucleotide primer sets, probes, and combinations of the primer sets and probes are provided herein. These reagents are useful for amplifying and detecting HIV-1 target sequences in a test sample.

Claims (17)

1. A probe selected from the group consisting of:

SEQ ID NO: 41; SEQ ID NO: 42; SEQ ID NO: 43; SEQ ID NO: 44; SEQ ID NO: 45; SEQ ID NO: 46; SEQ ID NO: 47; SEQ ID NO: 48; SEQ ID NO: 49; SEQ ID NO: 58; SEQ ID NO: 59; SEQ ID NO: 60; SEQ ID NO: 61; SEQ ID NO: 62; SEQ ID NO: 63; SEQ ID NO: 64; and SEQ ID NO: 65.

2. The probe of claim 1 , wherein the probe is selected from the group consisting of: SEQ ID NO: 41; SEQ ID NO: 42; SEQ ID NO: 45; SEQ ID NO: 48; and SEQ ID NO: 49.

3. A method for detecting the presence of HIV-1 in a test sample comprising:

contacting a test sample with amplification reagents;

placing the reaction mixture under amplification conditions to form an amplification product;

forming a hybrid between the amplification product and a probe selected from the group consisting of SEQ ID NO: 41; SEQ ID NO: 42; SEQ ID NO: 43; SEQ ID NO: 44; SEQ ID NO: 45; SEQ ID NO: 46; SEQ ID NO: 47; SEQ ID NO: 48; SEQ ID NO: 49; SEQ ID NO: 58; SEQ ID NO: 59; SEQ ID NO: 60; SEQ ID NO: 61; SEQ ID NO: 62; SEQ ID NO: 63; SEQ ID NO: 64; and SEQ ID NO: 65; and

detecting the hybrid as an indication of the presence of HIV-1 in the test sample.

4. The method of claim 3 wherein the hybrid is formed while the reaction mixture is under amplification conditions.

5. The method of claim 3 ,

wherein the probe is selected from the group consisting of SEQ ID NO: 41, SEQ ID NO: 42, SEQ ID NO: 43, SEQ ID NO: 44, SEQ ID NO: 45, SEQ ID NO: 46, SEQ ID NO: 47 and SEQ ID NO: 48, and

wherein the amplification reagents comprise SEQ ID NO: 28.

6. The method of claim 5 , wherein the amplification reagents include a primers selected from the group consisting of:

SEQ ID NO: 28 and SEQ ID NO: 29, SEQ ID NO: 28 and SEQ ID NO: 30, SEQ ID NO: 28 and SEQ ID NO: 31, SEQ ID NO: 28 and SEQ ID NO: 32, and SEQ ID NO: 28 and SEQ ID NO: 33.

7. The method of claim 3 , wherein the probe comprises SEQ ID NO: 49 and wherein the amplification reagents comprise SEQ ID NO: 28.

8. The method of claim 7 , wherein the amplification reagents include a primers selected from the group consisting of:

SEQ ID NO: 28 and SEQ ID NO: 29, SEQ ID NO: 28 and SEQ ID NO: 30, SEQ ID NO: 28 and SEQ ID NO: 32, and SEQ ID NO: 28 and SEQ ID NO: 33.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2001
From: HARRIS, BARBARA J.; HACKETT JR., JOHN R.; SWANSON, PRISCILLA; ABRAVAYA, KLARA; GORZOWSKI, JACEK J.; TANG, NING; DEVARE, SUSHIL G.; ESPING, CLAUDIA A.
To: ABBOTT LABORATORIES
Reel/Frame 012257/0188 →
Continuity (1)
Related Publication 20030148280A1 · Aug 7, 2003